Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
BMC Musculoskeletal Disorders|October 1, 2025
Body composition, bone mineral density, and functional impairment in axial spondyloarthritis: a 36-month longitudinal studyChiara Ceolin, Sara Bindoli, Giacomo Cozzi, et al.
Cancer Research|November 20, 2002
Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increaseMaria Letizia Taddei, Paola Chiarugi, Paolo Cirri, et al.
Seminars in Arthritis and Rheumatism|July 15, 2023
Treat-to-target in real-life psoriatic arthritis patients: achieving minimal disease activity with bDMARDs/tsDMARDs and potential barriersAugusta Ortolan, Mariagrazia Lorenzin, Giacomo Cozzi, et al.
Frontiers in Immunology|August 11, 2023
The impact of SARS-CoV-2 infection and vaccination on inflammatory arthritis: a cohort studyGiovanni Striani, Ariela Hoxha, Mariagrazia Lorenzin, et al.
Plos One|March 6, 2026
Correction: Ketogenic diet improves disease activity and cardiovascular risk in psoriatic arthritis: A proof of concept studyRoberta Ramonda, Francesca Ometto, Giovanni Striani, et al.
Plos One|April 22, 2025
Ketogenic diet improves disease activity and cardiovascular risk in psoriatic arthritis: A proof of concept studyRoberta Ramonda, Francesca Ometto, Giovanni Striani, et al.
Clinical and Experimental Rheumatology|July 14, 2026
Do DMARDs increase the risk of cancer recurrence in patients with spondyloarthritis, psoriatic arthritis and rheumatoid arthritis?Laura Scagnellato, Giacomo Cozzi, Mariagrazia Lorenzin, et al.
Clinical and Experimental Rheumatology|August 5, 2022
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohortMichela Gasparotto, Sara Bindoli, Roberto Padoan, et al.
Therapeutic Advances in Musculoskeletal Disease|May 4, 2026
A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian studyStefano Gentileschi, Carla Gaggiano, Francesco Placido, et al.
Frontiers in Immunology|July 30, 2024
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritisRoberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Pageof 4